Status:
COMPLETED
Efficacy Evaluation of a Mixed Compound of Antioxidants in Terms of Endothelium Damage/Function in Pediatric Subjects With Obesity.
Lead Sponsor:
Universita di Verona
Conditions:
Childhood Obesity
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
The aim of our study was to test the effects on endothelium of a combination of curcumin, resveratrol, plus zinc, magnesium, selenium and Vitamin D in a cohort of pediatric subjects with obesity.
Detailed Description
The aim of our study was to test the effects on endothelium of a combination of curcumin, resveratrol, plus zinc, magnesium, selenium and Vitamin D in a cohort of pediatric subjects with obesity. Endo...
Eligibility Criteria
Inclusion
- Diagnosis of obesity as defined by a BMI higher than the 95 percentile for age based on the CDC standard
- Age 6-17 years
Exclusion
- Children with genetic syndromes or cardiovascular diseases were excluded from the study
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT04723849
Start Date
February 1 2019
End Date
July 31 2020
Last Update
January 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Verona
Verona, Italy